Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11a

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Respiratory Journal

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1183/09031936.00122509PMID 20110398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009cited by this paper
• A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non-cystic fibrosis-like phenotype.

  2009cited by this paper
• Chloride channels as drug targets

  2009cited by this paper
• Palmatine, a protoberberine alkaloid, inhibits both Ca2+‐ and cAMP‐activated Cl− secretion in isolated rat distal colon

  2008cited by this paper
• Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr-/- mice.

  2008cited by this paper
• Anti-inflammatory effect of miglustat in bronchial epithelial cells.

  2008cited by this paper
• Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR.

  2008cited by this paper
• CFTR inhibition by glibenclamide requires a positive charge in cytoplasmic loop three.

  2007cited by this paper
• Discovery of α-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels

  2007cited by this paper
• Rescue of functional delF508‐CFTR channels in cystic fibrosis epithelial cells by the α‐glucosidase inhibitor miglustat

  2006cited by this paper
• The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants.

  2006cited by this paper
• Discovery of Pyrrolo[2,3-b]pyrazines Derivatives as Submicromolar Affinity Activators of Wild Type, G551D, and F508del Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels

  2006cited by this paper
• On the discovery and development of CFTR chloride channel activators.

  2006cited by this paper
• The Glycine Residues G551 and G1349 within the ATP-Binding Cassette Signature Motifs Play Critical Roles in the Activation and Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator Channels by Phloxine B

  2006cited by this paper
• Rescue of ΔF508-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) by Curcumin: Involvement of the Keratin 18 Network

  2006cited by this paper
• Salivary secretion assay for drug efficacy for cystic fibrosis in mice

  2005cited by this paper
• Failure of cAMP agonists to activate rescued ΔF508 CFTR in CFBE41o– airway epithelial monolayers

  2005cited by this paper
• Determination of CFTR chloride channel activity and pharmacology using radiotracer flux methods.

  2004cited by this paper
• Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis.

  2004cited by this paper
• Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors

  2004cited by this paper
• Identification of CFTR activators and inhibitors: chance or design?

  2004cited by this paper
• The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.

  2004cited by this paper
• Nanomolar Affinity Small Molecule Correctors of Defective ΔF508-CFTR Chloride Channel Gating*

  2003cited by this paper
• Pharmacological modulators of voltage-gated calcium channels and their therapeutical application.

  2003cited by this paper
• GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?

  2003cited by this paper
• Cystic fibrosis

  2003cited by this paper
• Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.

  2003cited by this paper
• New stereoselective reaction of methylglyoxal with 2-aminopyridine and adenine derivatives: formation of imino acid-nucleic base derivatives in water under mild conditions.

  2002cited by this paper
• Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

  2002cited by this paper
• Deletion of phenylalanine 508 causes attenuated phosphorylation‐dependent activation of CFTR chloride channels

  2000cited by this paper
• Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells.

  2000cited by this paper
• Structure and function of the CFTR chloride channel.

  1999cited by this paper
• Pharmacology of CFTR chloride channel activity.

  1999cited by this paper
• Activation of wild-type and ΔF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms

  1999cited by this paper
• Actions of Genistein on Cystic Fibrosis Transmembrane Conductance Regulator Channel Gating

  1998cited by this paper
• Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: Study of 19 heterozygous and 2 homozygous patients

  1997cited by this paper
• Cystic Fibrosis Phenotype Associated with Pancreatic Insufficiency Does Not Always Reflect the cAMP-dependent Chloride Conductive Pathway Defect

  1997cited by this paper
• Genistein potentiates wild-type and delta F508-CFTR channel activity.

  1997cited by this paper
• Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines.

  1996cited by this paper
• Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone.

  1994cited by this paper
• cAMP-regulated whole cell chloride currents in pancreatic duct cells.

  1993cited by this paper
• Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene.

  1993cited by this paper
• Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

  1991cited by this paper
• Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation

  1991cited by this paper
• Nucleoside triphosphates are required to open the CFTR chloride channel.

  1991cited by this paper

• Overview of CFTR activators and their recent studies for dry eye disease: a review.

  2023cites this paper
• Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response

  2021cites this paper
• Gata2 in Hematopoietic Cell Generation

  2017cites this paper
• A functional tandem between transient receptor potential canonical channels 6 and calcium-dependent chloride channels in human epithelial cells.

  2015cites this paper
• A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.

  2014cites this paper
• Fonction de CFTR dans les processus de réparation de l’épithélium des voies aériennes et développement de nouvelles stratégies thérapeutiques en fibrose kystique

  2014cites this paper
• Repairing mutated proteins – development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator

  2013cites this paper
• Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.

  2012cites this paper
• An expeditious access to 5-pyrimidinol derivatives from cyclic methylglyoxal diadducts, formation of argpyrimidines under physiological conditions and discovery of new CFTR inhibitors.

  2011cites this paper
• Pharmacological therapy for cystic fibrosis: from bench to bedside.

  2011cites this paper
• CFTR Modulators for the Treatment of Cystic Fibrosis

  2010cites this paper
• Identification of Synergistic Combinations of F508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators

  2010cites this paper